Molecular imaging of impulse control disorders in Parkinson's disease

Joonas Majuri¹, Juho Joutsa^{2

3}

Affiliations

¹ Department of Neurology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, FI-15850, Lahti, Finland. joeema@utu.fi.
² Turku Brain and Mind Center and Department of Neurology, University of Turku, Turku, Finland.
³ Division of Clinical Neurosciences and Turku PET Centre, Turku University Hospital, Turku, Finland.

Editorial

Joonas Majuri et al. Eur J Nucl Med Mol Imaging. 2019 Oct.

. 2019 Oct;46(11):2220-2222.

doi: 10.1007/s00259-019-04459-5. Epub 2019 Jul 31.

Joonas Majuri¹, Juho Joutsa^{2

3}

¹ Department of Neurology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, FI-15850, Lahti, Finland. joeema@utu.fi.
² Turku Brain and Mind Center and Department of Neurology, University of Turku, Turku, Finland.
³ Division of Clinical Neurosciences and Turku PET Centre, Turku University Hospital, Turku, Finland.

No abstract available

Comment on

Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Peñin A, Jimenez-Urbieta H, Delgado-Alvarado M, Gago B, Quiroga-Varela A, Rodriguez-Oroz MC. Navalpotro-Gomez I, et al. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2065-2076. doi: 10.1007/s00259-019-04396-3. Epub 2019 Jul 4. Eur J Nucl Med Mol Imaging. 2019. PMID: 31273436